3|0|Public
50|$|<b>Estrapronicate</b> (INN), {{also known}} as {{estradiol}} 17-nicotinate 3-propionate is a synthetic, steroidal estrogen and estradiol ester that was never marketed. It was studied {{as a component of}} the experimental tristeroid combination drug Trophobolene, which contained nandrolone decanoate, <b>estrapronicate,</b> and hydroxyprogesterone heptanoate.|$|E
50|$|Estradiol 3-propionate, or 3-propanoylestradiol, {{also known}} as estra-1,3,5(10)-trien-3,17β-diol 3-propionate, is a semisynthetic, steroidal {{estrogen}} that was never marketed. It is an estrogen ester, specifically, a propionic acid ester of estradiol, and acts as a prodrug to it in vivo. The chemical structure of estradiol 3-propionate is contained within estradiol dipropionate, <b>estrapronicate,</b> and orestrate, {{all of which are}} also estradiol esters.|$|E
50|$|Hydroxyprogesterone heptanoate (brand names H.O.P., Lutogil A.P., Lutogyl A.P.), or 17α-{{hydroxyprogesterone}} heptanoate, {{also known}} as hydroxyprogesterone enanthate, is a steroidal progestin of the 17α-hydroxyprogesterone group that was developed by Roussel and Théramex and has been used clinically in France and Monaco. It was {{a component of the}} experimental preparation Trophoboline (or Trophobolene), which also contained nandrolone decanoate and <b>estrapronicate.</b> It was also studied or used in Tocogestan, a combination of hydroxyprogesterone heptanoate (200 mg), progesterone (50 mg), and tocopherol (250 mg) oil for intramuscular injection.|$|E

